In infections and rejections following heart transplantation, DLL1 was also described as marker within patients suffering from chronic heart failure or dilatative cardiomyopathy [34,35] as well as non-small cell lung cancer (NSCLC) and chronic obstructive pulmonary disease (COPD) [36]. Here, DLL1 is linked to dilated cardiomyopathy.